Pharaoh Neuro

Pharaoh Neuro operates at the intersection of medical devices, neurotechnology, and neurocritical care. Its stated focus is on tools for high-stakes neurointerventional settings, with a neurapheresis platform addressing cerebrospinal fluid management and the MindsEye™ Expandable Port adding a second device to its portfolio. Pharaoh Neuro is a small company, with an employee range of 1–10, and its $20 million Series A places it at an early, development-oriented stage compared with established medical-device businesses. The available company-comparison entries do not identify independent competitors, so naming specific rivals would not be reliable. Its differentiators, based on the disclosed profile, are its concentration on cerebrospinal fluid management, its neurocritical-care orientation, and a portfolio spanning neurapheresis and an expandable port. Evidence about market share, reimbursement, and competitive performance is limited.

The company’s visible growth inflection point is its February 2026 Series A: Pharaoh Neuro raised $20 million on February 18, led by Arboretum Ventures, alongside three other investors. That financing is consistent with a company building out regulated medical-device programs, though no use-of-proceeds plan or subsequent operational milestones are specified. Leadership changes followed in the same month: Amaza Reitmeier became CEO, and Shivanand Lad joined the leadership roster as CMO and co-founder. Aaron McCabe is listed as chief scientific and technology officer, while founders Mark Wagner and Rich Nazarian hold director and board roles. The disclosed team size remains in the 1–10 employee band, and there is no reported hiring plan or employee-growth series from which to infer acceleration. The MindsEye™ Expandable Port has FDA 510(k) clearance, providing a product-development milestone, while the neurapheresis platform remains a central part of the company’s stated focus. The next meaningful indicators of trajectory would be documented clinical progress, commercialization, or team expansion; none is detailed here.